LONGITUDINAL MONITORING OF THE LEVODOPA CONCENTRATION-EFFECT RELATIONSHIP IN PARKINSONS-DISEASE

We prospectively evaluated over 4 years the intrasubject relationship between levodopa plasma concentration and the tapping effect after a standard oral levodopa test in 28 patients with mild-to-moderate idiopathic Parkinson's disease. The onset and duration of the tapping effect significantly shortened over years; response amplitude did not vary. Levodopa plasma kinetics remained unchanged. Pharmacodynamic modeling indicated a progressive decrease in the equilibration half-life between plasma drug concentration and effect, which correlated with the shorter motor response. No clear-cut change in maximum response (E(max)) emerged, but levodopa concentration needed to yield 50% of maximum effect (EC(50)) significantly increased. These data indicate that the duration of motor response becomes a major determinant of drug efficacy over years. The modifications in levodopa effect-compartment equilibration half-life and EC(50) further support the suggestion that alterations in cerebral levodopa kinetics have an important role in the development of response fluctuations.